Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, or $0.08 per share annually, on its common stock. The dividend is payable on or about May 15, 2026 to stockholders of record on March 31, 2026. The company expects subsequent dividends to be paid within 45 days after each fiscal quarter end.
ReposiTrak, Inc.’s Form 4 shows an open-market sale of 7,500 shares of Common Stock at a weighted average price of $8.0596 per share. The sale was made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan to help meet charitable commitments.
After this transaction, that LLC holds 70,000 ReposiTrak shares indirectly for Randall K. Fields. The filing also reports Fields directly owning 3,483,955 Common shares, along with additional indirect holdings, including 615,260 Common shares via Riverview Financial Corp., 333,643 via Fields Management, Inc., and related Series B Preferred Stock positions.
ReposiTrak, Inc. director James R. Gillis filed a Form 3, which is an initial statement of beneficial ownership of company securities. This filing simply establishes his status as an insider and does not report any stock purchases, sales, option exercises, or other transactions.
ReposiTrak, Inc., through its subsidiary PC Group, entered into a strategic financing arrangement with SPAR Marketing Force, Inc. via a senior unsecured promissory note of up to $4,000,000. The facility includes an initial $3,000,000 advance and an additional $1,000,000 available beginning July 17, 2026.
The note carries 8.0% annual interest, payable monthly on an interest-only basis, and matures on March 16, 2029. As part of the deal, PC Group is to receive 1,000,000 shares of SPAR Group common stock at a deemed value of $0.80 per share, with anti-dilution and price protection features.
SPAR Group, Inc. guarantees the borrower’s obligations. The agreement includes customary default triggers, after which the interest rate increases to 12.0% and PC Group can accelerate repayment.
ReposiTrak, Inc. director and CEO Randall K. Fields reported pre-planned insider sales executed by a charitable entity associated with him. RK Fields Charitable 2022, LLC sold a total of 7,500 shares of ReposiTrak common stock in open-market transactions on March 16–17, 2026 at weighted average prices slightly above $8 per share.
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the related charitable trust to help meet charitable commitments. After these sales, that LLC held 77,500 shares. The Form 4 also shows Fields continues to hold 3,483,955 ReposiTrak common shares directly, plus additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. filed a current report describing the return of James R. Gillis to its Board of Directors, effective March 13, 2026. He will also serve on the Audit and Compensation Committees. The Board determined that he qualifies as an independent director under New York Stock Exchange listing standards.
Gillis is CEO of Gillis & Associates, Inc., an M&A advisory firm, and previously served on ReposiTrak’s board from 2008 to 2015. He has more than 35 years of experience in retail supply chain management, mergers and acquisitions, and organizational growth, and currently holds multiple other board and advisory roles.
ReposiTrak, Inc. director and CEO Randall K. Fields reported an indirect open-market sale of 4,000 shares of Common Stock at a weighted average price of $8.0599 per share. The shares were sold by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments, with individual trade prices ranging from $7.91 to $8.17. Following the sale, that LLC holds 85,000 shares, while Fields also reports 3,483,955 shares held directly and additional indirect positions through affiliated entities and his spouse.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported that RK Fields Charitable 2022, LLC, an entity he manages as trustee of a charitable remainder unitrust, sold 3,500 shares of common stock on March 9, 2026 at a weighted average price of $8.5612 per share.
The sale was executed automatically under a pre-established Rule 10b5-1 trading plan designed to help meet charitable commitments. After this transaction, that LLC held 89,000 shares, while Fields also reported 3,483,955 shares held directly and additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. reported that an entity associated with Chief Executive Officer Randall K. Fields sold a total of 7,500 shares of common stock in open‑market transactions. The sales, made by RK Fields Charitable 2022, LLC under a Rule 10b5‑1 trading plan, occurred on March 2, 3, and 4, 2026 at weighted average prices of $8.75, $8.55, and $8.6182 per share, respectively.
The trading plan was adopted by Mr. Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments. After these sales, RK Fields Charitable 2022, LLC held 92,500 shares of common stock. The filing also lists additional direct and indirect holdings, including 3,483,955 common shares held directly as of March 2, 2026, along with stakes held through Riverview Financial Corp., Fields Management, Inc., and by his spouse, plus holdings of Series B Preferred Stock through Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect sales of company common stock through an affiliated charitable entity. RK Fields Charitable 2022, LLC sold 7,500 shares in open-market transactions, consisting of 5,300 shares on February 25, 2026 at a weighted average price of $8.3369 per share and 2,200 shares on February 24, 2026 at a weighted average price of $8.5026 per share. According to the disclosure, these sales occurred automatically under a pre-established Rule 10b5‑1 trading plan adopted by Fields in his capacity as trustee of a charitable remainder unitrust to help meet charitable commitments, and RK Fields Charitable 2022, LLC held 100,000 shares of ReposiTrak common stock after the transactions.